# Humanity & Health

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/humanity-and-health/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 77 |
| Citations | 19,567 |
| City | Hong Kong |
| Country | CN |
| Description | Humanity & Health is a research organisation in Hong Kong, CN. OpenAlex records 597 works and 19,567 citations for it. 81 researchers list it as their most recent affiliation. |
| Homepage | http://www.hnhmgl.com/en/ |
| OpenAlex ID | https://openalex.org/I4210095947 |
| Region | Hong Kong |
| Researchers | 81 |
| ROR ID | https://ror.org/00p36v374 |
| Type | healthcare |
| Works | 597 |

## University papers

- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update](https://scholariq.org/papers/acute-on-chronic-liver-failure-consensus-recommendations-of-the-asian-pacific-2/)
- [Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)](https://scholariq.org/papers/acute-on-chronic-liver-failure-consensus-recommendations-of-the-asian-pacific-3/)
- [Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy](https://scholariq.org/papers/early-is-superior-to-deferred-preemptive-lamivudine-therapy-for-hepatitis-b/)
- [Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma](https://scholariq.org/papers/four-year-overall-survival-update-from-the-phase-iii-himalaya-study-of/)
- [Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)](https://scholariq.org/papers/pre-existing-liver-disease-is-associated-with-poor-outcome-in-patients-with-sars/)
- [Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models](https://scholariq.org/papers/liver-failure-determines-the-outcome-in-patients-of-acute-on-chronic-liver/)

## University top topics

Showing 8 of 18.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Education, Healthcare and Sociology Research](https://scholariq.org/topics/education-healthcare-and-sociology-research/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Social and Educational Sciences](https://scholariq.org/topics/social-and-educational-sciences/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.